When backpacks have become ergonomic, dependable, hard-wearing, and supremely organized, where does innovation lead next? Weight reduction. Ultralight packs have steadily gained popularity over the ...
I recently had the chance to test Gossamer Gear s Ultralight Loris 25 Daypack, on a whirlwind of adventures across Scotland, Costa Rica, and the Faroe Islands while filming for our Epic Trails TV ...
SAN DIEGO, December 09, 2025--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for ...
Gossamer Bio's consensus analyst price target has recently risen from $8.86 to $9.50, which signals a more optimistic outlook among market observers. This adjustment comes as analyst sentiment grows ...
Investing.com - Cantor Fitzgerald has maintained its Overweight rating on Gossamer Bio Inc. (NASDAQ:GOSS) as the company’s seralutinib clinical trial approaches a significant milestone. The stock, ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251105312270/en/ The articles, information, and content displayed on this webpage ...
Today, we take a look at clinical-stage biopharma firm Gossamer Bio, whose stock is up some 175% so far in 2025. Seralutinib, Gossamer's lead asset, is advancing to late-stage development and has ...
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the biotech stocks to buy according to Wall Street analysts. On July 14, Scotiabank initiated coverage of Gossamer Bio with an Outperform rating and an $11 ...
Fintel reports that on July 14, 2025, Scotiabank initiated coverage of Gossamer Bio (NasdaqGS:GOSS) with a Sector Outperform recommendation. Analyst Price Forecast Suggests 470.53% Upside As of June ...
A.I. has yet to upend Hollywood. But it is starting to make big inroads in animation. The founders of Toonstar, a small animation studio in downtown Los Angeles, have incorporated A.I. at various ...
Chuck Jones's 'Water, Water Every Hare' is significantly better than its truly dreadful title. Pitting Bugs against a bulbously headed green faced scientist and his furry orange, sneaker wearing ...